Tempus AI offers a strong business model with AI-driven genomic data, resilient demand, and significant growth prospects.

Tempus AI's growth is fueled by data services and acquisitions, despite financial risks. Key Q2 results may shape its path to ...

Coupled with revised estimates for federal grants, gaming receipts, fines, fees and other miscellaneous revenues, Lamont’s ...

Tempus AI (TEM) recently secured FDA clearance for its Tempus ECG-Low EF software and expanded its collaboration with Personalis for colorectal cancer detection, measures that collectively ...

Tempus AI, Inc. TEM recently introduced xM for treatment response monitoring (TRM), a liquid biopsy assay. It is designed to ...

Tempus AI and NVIDIA are both actively working at the intersection of AI and healthcare. Tempus AI, while advancing precision ...

With a trading volume of 7,459,075, the price of TEM is down by -4.37%, reaching $59.29. Current RSI values indicate that the stock is is currently neutral between overbought and oversold. Next ...

Tempus AI TEM and NVIDIA NVDA are both actively working at the intersection of AI and healthcare. Tempus AI, while advancing ...

Chancellor, business and civic leaders honor College’s legacy, look to the future Tarrant County College marks a milestone today, celebrating 60 years of l ...

Activists with the pro-housing YIMBY movement have scored win after win at the California Legislature in recent years.

In July 2025, Janssen Research & Development LLC conducted a study is to evaluate the efficacy of icotrokinra compared to ...

Attorney Ron Sokol weighs the merits about cases going to trial, if there’s a choice, or settling out of court.